Panelists discuss how the evolution of anal cancer treatment began with the 1974 Nigro regimen combining 5-fluorouracil and ...

Chemoradiation is a combination of chemotherapy drugs and radiation therapy. It’s usually not used for all types of cancers, but research shows it can be an effective treatment option for anal ...

Conclusions: Chemoradiation combined with immunotherapy as an adjuvant therapy demonstrated superior survival outcomes over observation in resectable ECC/GBC patients with a well-tolerable safety ...

The first UKCCCR Anal Cancer Trial (1996) demonstrated the benefit of chemoradiation over radiotherapy (RT) alone for treating epidermoid anal cancer, and it became the standard treatment.

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds. The results ...

Cite this: The Concurrent Chemoradiation Paradigm-General Principles - Medscape - Feb 01, 2007. Summary and Introduction Clinical Application—Disease Entities ...

A long course of chemoradiation therapy appeared associated with higher organ preservation rates vs. a short course among a cohort of patients with rectal cancer, according to a study presented at ...

A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made ...

WASHINGTON — Reduced doses of radiation therapy and immunotherapy did not work as well as the standard chemoradiation for early-stage HPV-associated oropharyngeal cancer, in a new study. These ...

Patients with locally advanced rectal cancer who underwent treatment with fluorouracil, leucovorin and oxaliplatin — a combination referred to as FOLFOX — before sphincter-sparing surgery had similar ...

Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III ...